Logo image of SQNS

SEQUANS COMMUNICATIONS-ADR (SQNS) Stock Fundamental Analysis

USA - NYSE:SQNS - US8173233060 - ADR

7.91 USD
+0.46 (+6.17%)
Last: 10/20/2025, 8:17:12 PM
7.97 USD
+0.06 (+0.76%)
After Hours: 10/20/2025, 8:17:12 PM
Fundamental Rating

3

Taking everything into account, SQNS scores 3 out of 10 in our fundamental rating. SQNS was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. There are concerns on the financial health of SQNS while its profitability can be described as average. While showing a medium growth rate, SQNS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

SQNS had negative earnings in the past year.
SQNS had a negative operating cash flow in the past year.
SQNS had negative earnings in 4 of the past 5 years.
SQNS had a negative operating cash flow in each of the past 5 years.
SQNS Yearly Net Income VS EBIT VS OCF VS FCFSQNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

SQNS has a better Return On Assets (61.05%) than 99.11% of its industry peers.
SQNS has a Return On Equity of 129.98%. This is amongst the best in the industry. SQNS outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 61.05%
ROE 129.98%
ROIC N/A
ROA(3y)2.44%
ROA(5y)-15.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SQNS Yearly ROA, ROE, ROICSQNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K 2K

1.3 Margins

SQNS has a better Profit Margin (144.41%) than 100.00% of its industry peers.
Looking at the Gross Margin, with a value of 70.17%, SQNS belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
SQNS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 144.41%
GM 70.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.12%
GM growth 5Y13.43%
SQNS Yearly Profit, Operating, Gross MarginsSQNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 150

More info and screens

3

2. Health

2.1 Basic Checks

SQNS does not have a ROIC to compare to the WACC, probably because it is not profitable.
SQNS has more shares outstanding than it did 1 year ago.
SQNS has more shares outstanding than it did 5 years ago.
SQNS has a better debt/assets ratio than last year.
SQNS Yearly Shares OutstandingSQNS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
SQNS Yearly Total Debt VS Total AssetsSQNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 14.62 indicates that SQNS is not in any danger for bankruptcy at the moment.
SQNS has a Altman-Z score of 14.62. This is in the better half of the industry: SQNS outperforms 79.46% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that SQNS is not too dependend on debt financing.
The Debt to Equity ratio of SQNS (0.11) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 14.62
ROIC/WACCN/A
WACC11.16%
SQNS Yearly LT Debt VS Equity VS FCFSQNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

SQNS has a Current Ratio of 1.83. This is a normal value and indicates that SQNS is financially healthy and should not expect problems in meeting its short term obligations.
SQNS has a Current ratio of 1.83. This is in the lower half of the industry: SQNS underperforms 75.89% of its industry peers.
SQNS has a Quick Ratio of 1.75. This is a normal value and indicates that SQNS is financially healthy and should not expect problems in meeting its short term obligations.
SQNS has a Quick ratio of 1.75. This is in the lower half of the industry: SQNS underperforms 65.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.75
SQNS Yearly Current Assets VS Current LiabilitesSQNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for SQNS have decreased strongly by -91.03% in the last year.
SQNS shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.05%.
Measured over the past years, SQNS shows a small growth in Revenue. The Revenue has been growing by 3.60% on average per year.
EPS 1Y (TTM)-91.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1322.22%
Revenue 1Y (TTM)32.05%
Revenue growth 3Y-10.21%
Revenue growth 5Y3.6%
Sales Q2Q%-15.84%

3.2 Future

SQNS is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -33.17% yearly.
The Revenue is expected to grow by 20.27% on average over the next years. This is a very strong growth
EPS Next Y-421.15%
EPS Next 2Y-73.72%
EPS Next 3Y-33.17%
EPS Next 5YN/A
Revenue Next Year-18.4%
Revenue Next 2Y24.21%
Revenue Next 3Y20.27%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SQNS Yearly Revenue VS EstimatesSQNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
SQNS Yearly EPS VS EstimatesSQNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 -10 20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SQNS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SQNS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SQNS Price Earnings VS Forward Price EarningsSQNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SQNS Per share dataSQNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

A cheap valuation may be justified as SQNS's earnings are expected to decrease with -33.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-73.72%
EPS Next 3Y-33.17%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SQNS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SEQUANS COMMUNICATIONS-ADR

NYSE:SQNS (10/20/2025, 8:17:12 PM)

After market: 7.97 +0.06 (+0.76%)

7.91

+0.46 (+6.17%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners47.5%
Inst Owner Change0%
Ins Owners1.05%
Ins Owner ChangeN/A
Market Cap1.13B
Analysts82.5
Price Target56.1 (609.23%)
Short Float %N/A
Short Ratio0.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.83%
Min EPS beat(2)-1.2%
Max EPS beat(2)18.86%
EPS beat(4)2
Avg EPS beat(4)216.6%
Min EPS beat(4)-12.04%
Max EPS beat(4)860.78%
EPS beat(8)4
Avg EPS beat(8)101.43%
EPS beat(12)7
Avg EPS beat(12)80.87%
EPS beat(16)11
Avg EPS beat(16)71.46%
Revenue beat(2)1
Avg Revenue beat(2)-19.25%
Min Revenue beat(2)-48.17%
Max Revenue beat(2)9.67%
Revenue beat(4)3
Avg Revenue beat(4)17.48%
Min Revenue beat(4)-48.17%
Max Revenue beat(4)105.88%
Revenue beat(8)4
Avg Revenue beat(8)-0.97%
Revenue beat(12)5
Avg Revenue beat(12)-1.82%
Revenue beat(16)5
Avg Revenue beat(16)-2.04%
PT rev (1m)900%
PT rev (3m)633.33%
EPS NQ rev (1m)-900%
EPS NQ rev (3m)-650%
EPS NY rev (1m)-563.55%
EPS NY rev (3m)-655.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-30.52%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-13.64%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 30.37
P/FCF N/A
P/OCF N/A
P/B 27.34
P/tB 39.99
EV/EBITDA N/A
EPS(TTM)-2.77
EYN/A
EPS(NY)-2.29
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS0.26
BVpS0.29
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 61.05%
ROE 129.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 144.41%
GM 70.17%
FCFM N/A
ROA(3y)2.44%
ROA(5y)-15.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.12%
GM growth 5Y13.43%
F-Score5
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 76.17%
Cap/Sales 13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.75
Altman-Z 14.62
F-Score5
WACC11.16%
ROIC/WACCN/A
Cap/Depr(3y)234.19%
Cap/Depr(5y)223.55%
Cap/Sales(3y)59.67%
Cap/Sales(5y)52.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-91.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1322.22%
EPS Next Y-421.15%
EPS Next 2Y-73.72%
EPS Next 3Y-33.17%
EPS Next 5YN/A
Revenue 1Y (TTM)32.05%
Revenue growth 3Y-10.21%
Revenue growth 5Y3.6%
Sales Q2Q%-15.84%
Revenue Next Year-18.4%
Revenue Next 2Y24.21%
Revenue Next 3Y20.27%
Revenue Next 5YN/A
EBIT growth 1Y8.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-3.65%
EBIT Next 3Y21.52%
EBIT Next 5YN/A
FCF growth 1Y-94.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6553.81%
OCF growth 3YN/A
OCF growth 5YN/A